Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Which Pharma Firm Increases US Prices The Most?

Mar 21 2017

• By Brenda Sandburg

US-Money-and-Pills_V2_1200x675

Related Content

Who Speaks For The White House On Drug Prices? Industry Better Hope It Is Not Donald Trump

Mar 14 2017

Insulin Pricing, PBM Relationships Under Government Microscope

Mar 17 2017

Where Will It End? Lilly’s US Price Concessions Increase 30% In 2016

Mar 02 2017

Pharma’s Pricing Debate Splinters As US Political Confrontation Looms

Jan 19 2017

Lilly’s Insulin Discounts Target High-Deductible Insurance Gaps

Dec 13 2016

Janssen's Drug Pricing Report Emphasizes Value Of Rebates

Mar 02 2017

Pharma Pricing, Non-Profit Ties Get Increasing Scrutiny From Prosecutors

Sep 14 2016

Related Companies

Eli Lilly and Company

Merck & Co., Inc.

Johnson & Johnson

Allergan plc

Novo Nordisk A/S

AbbVie Inc.

Roche Holding AG

Genentech, Inc.

Sanofi

Additional Topics

United States Pricing Debate Policy Pricing Strategies BioPharmaceutical

More from Drug Pricing

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window